Results 61 to 70 of about 11,201 (278)

Metastatic renal cell carcinoma presenting as a clear cell tumour in the head and neck region [PDF]

open access: yes, 2004
Renal cell carcinoma (RCC) is the most frequent urological malignancy in adults and has a male preponderance. It accounts for approximately 3% of adult malignancies and 90–95% of neoplasms arising from the kidney.
Jayasooriya, P.R   +3 more
core   +1 more source

Aptamer‐Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies

open access: yesAdvanced Healthcare Materials, EarlyView.
Aptamer‐based delivery systems targeting NGF and VEGF hold significant potential for precise and sustained treatment of complex diseases affecting both the anterior and posterior segments of the eye. This review critically summarizes current strategies for NGF and VEGF delivery as well as VEGF sequestration, providing a clinical perspective on how ...
Nadine Best   +5 more
wiley   +1 more source

Co-occurrence of Sebaceous Lymphadenoma with Pleomorphic Adenoma of Parotid Gland: A Rare Case Report [PDF]

open access: yesمجله علمی دانشگاه علوم پزشکی کردستان
Background and Aim: Sebaceous lymphadenoma is a rare neoplasm of the salivary gland. It is rarely diagnosed correctly pre-operatively. Sebaceous lymphadenoma remains benign for the most part and it does not transform into a malignant tumor. Co-occurrence
Maryam Akbari   +2 more
doaj  

Benign sebaceous gland tumor in a giant otter (Pteronura brasiliensis)

open access: yesBrazilian Journal of Veterinary Pathology
The giant otter (Pteronura brasiliensis) is the largest species in the Mustelidae family currently found on the Amazon, Cerrado, and Pantanal biomes, characterized by its semi-aquatic lifestyle.
Rodrigo Hidalgo Friciello Teixeira   +3 more
doaj   +1 more source

p63 expression in normal skin and usual cutaneous carcinomas [PDF]

open access: yes, 2002
Background: p63 is a p53 homologue that is mapped to chromosome 3q27. This gene encodes six different isoforms, which have either transactivating or dominant negative effects on p53-reporter genes. It has been described that in contrast to p53, p63 seems
André Albergaria   +24 more
core   +3 more sources

Biomimetic Copper Nanoparticles Coated with ACE2‐Overexpressing Membranes for Selective SARS‐CoV‐2 Neutralization and Disinfection

open access: yesAdvanced Healthcare Materials, EarlyView.
By fusing ACE2‐overexpressing membrane‐integrated liposome (MIL) with copper nanoparticles, the biomimetic Cu@MIL nanostructures were created that directly hijack the SARS‐CoV‐2 entry pathway. These particles combine potent virus‐targeting precision with intrinsic antiviral activity, achieving rapid neutralization and disinfection.
Pooja Aich   +8 more
wiley   +1 more source

Primary renal teratoma: a rare entity [PDF]

open access: yes, 2013
: Teratomas are neoplasms that arise from pluripotent cells and can differentiate along one or more embryonic germ lines. Renal teratoma is an exceedingly rare condition.
Afaf Amarti   +7 more
core   +1 more source

Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction

open access: yesAdvanced Healthcare Materials, EarlyView.
Atherosclerosis management is hindered by poor drug targeting and plaque heterogeneity. Nanotechnology overcomes these barriers via three core strategies: (1) target‐engineered nanocarriers that achieve lesion‐specific precision via ligand modification, biomimetic camouflage, stimuli‐responsive release, and self‐propelling nanomotors; (2) catalytic ...
Yuqi Yang   +4 more
wiley   +1 more source

ITALIAN CANCER FIGURES - REPORT 2015: The burden of rare cancers in Italy = I TUMORI IN ITALIA - RAPPORTO 2015: I tumori rari in Italia [PDF]

open access: yes, 2016
OBJECTIVES: This collaborative study, based on data collected by the network of Italian Cancer Registries (AIRTUM), describes the burden of rare cancers in Italy.
Adamo, Ms   +374 more
core   +1 more source

Consumed by Abdominal Distention

open access: yes
Arthritis Care &Research, EarlyView.
Abimbola Fadairo‐Azinge   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy